speb/financial-data huggingface dataset:
CTRN cash_flow (annual, 2024-01-31) — Change In Inventory: -24638000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Other Current Assets: 178000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Other Working Capital: -3508000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Payable: 17861000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Payables And Accrued Expense: -44434000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Prepaid Assets: 2179000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Working Capital: -70223000.00
CTRN cash_flow (annual, 2024-01-31) — Changes In Cash: -23789000.00
CTRN balance_sheet (annual, 2024-01-31) — Common Stock: 160000.00
CTRN balance_sheet (annual, 2024-01-31) — Common Stock Equity: 157706000.00
CTRN cash_flow (annual, 2024-01-31) — Common Stock Payments: 0.00
CTRN balance_sheet (annual, 2024-01-31) — Construction In Progress: 1102000.00
CTRN income_statement (annual, 2024-01-31) — Cost Of Revenue: 462824000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Accrued Expenses: 16466000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Assets: 225099000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Capital Lease Obligation: 45842000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Debt And Capital Lease Obligation: 45842000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Deferred Liabilities: 384000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Deferred Revenue: 384000.00
CTRN balance_sheet (annual, 2024-01-31) — Current Liabilities: 169904000.00
CTRN cash_flow (annual, 2024-01-31) — Deferred Income Tax: -2211000.00
CTRN cash_flow (annual, 2024-01-31) — Deferred Tax: -2211000.00
CTRN cash_flow (annual, 2024-01-31) — Depreciation: 18990000.00
CTRN cash_flow (annual, 2024-01-31) — Depreciation Amortization Depletion: 18990000.00
CTRN income_statement (annual, 2024-01-31) — Depreciation Amortization Depletion Income Statement: 18990000.00
CTRN cash_flow (annual, 2024-01-31) — Depreciation And Amortization: 18990000.00
CTRN income_statement (annual, 2024-01-31) — Depreciation And Amortization In Income Statement: 18990000.00
CTRN income_statement (annual, 2024-01-31) — Depreciation Income Statement: 18990000.00
CTRN income_statement (annual, 2024-01-31) — Diluted Average Shares: 8221000.00
CTRN income_statement (annual, 2024-01-31) — Diluted EPS: -1.46
CTRN income_statement (annual, 2024-01-31) — Diluted NI Availto Com Stockholders: -11979000.00
CTRN income_statement (annual, 2024-01-31) — EBIT: -15580000.00
CTRN income_statement (annual, 2024-01-31) — EBITDA: 3410000.00
CTRN cash_flow (annual, 2024-01-31) — End Cash Position: 79706000.00
CTRN cash_flow (annual, 2024-01-31) — Financing Cash Flow: -854000.00
CTRN cash_flow (annual, 2024-01-31) — Free Cash Flow: -24452000.00
CTRN cash_flow (annual, 2024-01-31) — Gain Loss On Sale Of PPE: 238000.00
CTRN income_statement (annual, 2024-01-31) — Gain On Sale Of Ppe: 0.00
CTRN balance_sheet (annual, 2024-01-31) — Gross PPE: 563958000.00
CTRN income_statement (annual, 2024-01-31) — Gross Profit: 285117000.00
CTRN income_statement (annual, 2024-01-31) — Impairment Of Capital Assets: 1051000.00
CTRN cash_flow (annual, 2024-01-31) — Income Tax Paid Supplemental Data: 1813000.00
CTRN income_statement (annual, 2024-01-31) — Interest Expense: 306000.00
CTRN income_statement (annual, 2024-01-31) — Interest Expense Non Operating: 306000.00
CTRN income_statement (annual, 2024-01-31) — Interest Income: 3874000.00
CTRN income_statement (annual, 2024-01-31) — Interest Income Non Operating: 3874000.00
CTRN cash_flow (annual, 2024-01-31) — Interest Paid Supplemental Data: 159000.00
CTRN balance_sheet (annual, 2024-01-31) — Inventory: 130432000.00
CTRN balance_sheet (annual, 2024-01-31) — Invested Capital: 157706000.00
CTRN cash_flow (annual, 2024-01-31) — Investing Cash Flow: -13358000.00
CTRN balance_sheet (annual, 2024-01-31) — Leases: 131143000.00
CTRN balance_sheet (annual, 2024-01-31) — Long Term Capital Lease Obligation: 188810000.00
CTRN balance_sheet (annual, 2024-01-31) — Long Term Debt And Capital Lease Obligation: 188810000.00
CTRN balance_sheet (annual, 2024-01-31) — Machinery Furniture Equipment: 195646000.00
CTRN cash_flow (annual, 2024-01-31) — Net Common Stock Issuance: 0.00
CTRN income_statement (annual, 2024-01-31) — Net Income: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Income Common Stockholders: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Income Continuous Operations: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Income From Continuing And Discontinued Operation: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Income From Continuing Operation Net Minority Interest: -11979000.00
CTRN cash_flow (annual, 2024-01-31) — Net Income From Continuing Operations: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Income Including Noncontrolling Interests: -11979000.00
CTRN income_statement (annual, 2024-01-31) — Net Interest Income: 3568000.00
CTRN cash_flow (annual, 2024-01-31) — Net Investment Purchase And Sale: 0.00
CTRN income_statement (annual, 2024-01-31) — Net Non Operating Interest Income Expense: 3568000.00
CTRN cash_flow (annual, 2024-01-31) — Net Other Financing Charges: -854000.00
CTRN cash_flow (annual, 2024-01-31) — Net Other Investing Changes: 1517000.00
CTRN balance_sheet (annual, 2024-01-31) — Net PPE: 287512000.00
CTRN cash_flow (annual, 2024-01-31) — Net PPE Purchase And Sale: -14875000.00
CTRN balance_sheet (annual, 2024-01-31) — Net Tangible Assets: 157706000.00
CTRN balance_sheet (annual, 2024-01-31) — Non Current Deferred Assets: 5105000.00
CTRN balance_sheet (annual, 2024-01-31) — Non Current Deferred Liabilities: 0.00
CTRN balance_sheet (annual, 2024-01-31) — Non Current Deferred Taxes Assets: 5105000.00
CTRN balance_sheet (annual, 2024-01-31) — Non Current Deferred Taxes Liabilities: 0.00
CTRN income_statement (annual, 2024-01-31) — Normalized EBITDA: 4461000.00
CTRN income_statement (annual, 2024-01-31) — Normalized Income: -11186482.75
CTRN cash_flow (annual, 2024-01-31) — Operating Cash Flow: -9577000.00
CTRN cash_flow (annual, 2024-01-31) — Operating Gains Losses: 238000.00
CTRN income_statement (annual, 2024-01-31) — Operating Income: -18403000.00
CTRN income_statement (annual, 2024-01-31) — Operating Revenue: 747941000.00
CTRN balance_sheet (annual, 2024-01-31) — Ordinary Shares Number: 8550701.00
CTRN balance_sheet (annual, 2024-01-31) — Other Current Assets: 10838000.00
CTRN income_statement (annual, 2024-01-31) — Other Income Expense: -1051000.00
CTRN cash_flow (annual, 2024-01-31) — Other Non Cash Items: 50462000.00
CTRN balance_sheet (annual, 2024-01-31) — Other Non Current Assets: 1005000.00
CTRN balance_sheet (annual, 2024-01-31) — Other Non Current Liabilities: 2301000.00
CTRN balance_sheet (annual, 2024-01-31) — Other Properties: 231281000.00
CTRN balance_sheet (annual, 2024-01-31) — Payables: 100366000.00
CTRN balance_sheet (annual, 2024-01-31) — Payables And Accrued Expenses: 116832000.00
CTRN balance_sheet (annual, 2024-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 6846000.00
CTRN income_statement (annual, 2024-01-31) — Pretax Income: -15886000.00
CTRN balance_sheet (annual, 2024-01-31) — Properties: 0.00
CTRN cash_flow (annual, 2024-01-31) — Purchase Of Investment: 0.00
CTRN cash_flow (annual, 2024-01-31) — Purchase Of PPE: -14875000.00
CTRN balance_sheet (annual, 2024-01-31) — Receivables: 4123000.00
CTRN income_statement (annual, 2024-01-31) — Reconciled Cost Of Revenue: 462824000.00
CTRN income_statement (annual, 2024-01-31) — Reconciled Depreciation: 18990000.00
CTRN cash_flow (annual, 2024-01-31) — Repurchase Of Capital Stock: 0.00
CTRN balance_sheet (annual, 2024-01-31) — Retained Earnings: 319071000.00
CTRN cash_flow (annual, 2024-01-31) — Sale Of Investment: 0.00
CTRN cash_flow (annual, 2024-01-31) — Sale Of PPE: 0.00
CTRN income_statement (annual, 2024-01-31) — Selling General And Administration: 284530000.00
CTRN balance_sheet (annual, 2024-01-31) — Share Issued: 16354714.00
CTRN income_statement (annual, 2024-01-31) — Special Income Charges: -1051000.00
CTRN cash_flow (annual, 2024-01-31) — Stock Based Compensation: 4095000.00
CTRN balance_sheet (annual, 2024-01-31) — Stockholders Equity: 157706000.00
CTRN balance_sheet (annual, 2024-01-31) — Tangible Book Value: 157706000.00
CTRN income_statement (annual, 2024-01-31) — Tax Effect Of Unusual Items: -258482.75
CTRN income_statement (annual, 2024-01-31) — Tax Provision: -3907000.00
CTRN income_statement (annual, 2024-01-31) — Tax Rate For Calcs: 0.25
CTRN balance_sheet (annual, 2024-01-31) — Taxes Receivable: 4123000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Assets: 518721000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Capitalization: 157706000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Debt: 234652000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Equity Gross Minority Interest: 157706000.00
CTRN income_statement (annual, 2024-01-31) — Total Expenses: 766344000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Liabilities Net Minority Interest: 361015000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Non Current Assets: 293622000.00
CTRN balance_sheet (annual, 2024-01-31) — Total Non Current Liabilities Net Minority Interest: 191111000.00
CTRN income_statement (annual, 2024-01-31) — Total Operating Income As Reported: -19454000.00
CTRN income_statement (annual, 2024-01-31) — Total Unusual Items: -1051000.00
CTRN income_statement (annual, 2024-01-31) — Total Unusual Items Excluding Goodwill: -1051000.00
CTRN balance_sheet (annual, 2024-01-31) — Treasury Shares Number: 7804013.00
CTRN balance_sheet (annual, 2024-01-31) — Treasury Stock: 267211000.00
CTRN balance_sheet (annual, 2024-01-31) — Working Capital: 55195000.00
CTRN income_statement (quarterly, 2024-10-31) — Basic Average Shares: 8315000.00
CTRN income_statement (quarterly, 2024-10-31) — Basic EPS: -3.49
CTRN cash_flow (quarterly, 2024-10-31) — Common Stock Payments: 0.00
CTRN income_statement (quarterly, 2024-10-31) — Diluted EPS: -3.49
CTRN cash_flow (quarterly, 2024-10-31) — Net Common Stock Issuance: 0.00
CTRN balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Assets: 15301000.00
CTRN balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Taxes Assets: 15301000.00
CTRN cash_flow (quarterly, 2024-10-31) — Operating Gains Losses: 6000.00
CTRN income_statement (quarterly, 2024-10-31) — Other Income Expense: -574000.00
CTRN cash_flow (quarterly, 2024-10-31) — Repurchase Of Capital Stock: 0.00
CTRN cash_flow (quarterly, 2024-10-31) — Sale Of PPE: 0.00
CTRN balance_sheet (quarterly, 2024-10-31) — Treasury Shares Number: 7804013.00
CTRN income_statement (quarterly, 2024-10-31) — Write Off: 574000.00
CTRN income_statement (annual, 2025-01-31) — +Operating Expense: 318995000.00
CTRN income_statement (quarterly, 2025-01-31) — +Operating Expense: 81943000.00
CTRN income_statement (annual, 2025-01-31) — +Total Revenue: 753079000.00
CTRN income_statement (quarterly, 2025-01-31) — +Total Revenue: 211172000.00
CTRN balance_sheet (annual, 2025-01-31) — Accounts Payable: 102456000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 102456000.00
CTRN balance_sheet (annual, 2025-01-31) — Accumulated Depreciation: -297396000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -297396000.00
CTRN balance_sheet (annual, 2025-01-31) — Additional Paid In Capital: 108101000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 108101000.00
CTRN cash_flow (annual, 2025-01-31) — Asset Impairment Charge: 2536000.00
CTRN cash_flow (quarterly, 2025-01-31) — Asset Impairment Charge: 701000.00
CTRN income_statement (annual, 2025-01-31) — Basic Average Shares: 8315000.00
CTRN income_statement (annual, 2025-01-31) — Basic EPS: -5.19
CTRN cash_flow (annual, 2025-01-31) — Beginning Cash Position: 79706000.00
CTRN cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 38872000.00
CTRN balance_sheet (annual, 2025-01-31) — Buildings And Improvements: 4849000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Buildings And Improvements: 4849000.00
CTRN cash_flow (annual, 2025-01-31) — Capital Expenditure: -10108000.00
CTRN cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -2502000.00
CTRN balance_sheet (annual, 2025-01-31) — Capital Lease Obligations: 220399000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 220399000.00
CTRN balance_sheet (annual, 2025-01-31) — Capital Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Capital Stock: 162000.00
CTRN balance_sheet (annual, 2025-01-31) — Cash And Cash Equivalents: 61085000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 61085000.00
CTRN balance_sheet (annual, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 61085000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 61085000.00
CTRN cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Financing Activities: -4664000.00
CTRN cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: -3784000.00
CTRN cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Investing Activities: -10108000.00
CTRN cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -2502000.00
CTRN cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Operating Activities: -3849000.00
CTRN cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 28499000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Account Payable: 101000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Account Payable: 17999000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Accrued Expense: -49159000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Accrued Expense: -16128000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Inventory: 7792000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Inventory: 4874000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Other Current Assets: 160000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Other Current Assets: 40000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Other Working Capital: 1004000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: 462000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Payable: 101000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Payable: 17999000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Payables And Accrued Expense: -49058000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 1871000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Prepaid Assets: 626000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: 1769000.00
CTRN cash_flow (annual, 2025-01-31) — Change In Working Capital: -39476000.00
CTRN cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 9016000.00
CTRN cash_flow (annual, 2025-01-31) — Changes In Cash: -18621000.00
CTRN cash_flow (quarterly, 2025-01-31) — Changes In Cash: 22213000.00
CTRN balance_sheet (annual, 2025-01-31) — Common Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Common Stock: 162000.00
CTRN balance_sheet (annual, 2025-01-31) — Common Stock Equity: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 113176000.00
CTRN cash_flow (annual, 2025-01-31) — Common Stock Payments: -3777000.00
CTRN balance_sheet (annual, 2025-01-31) — Construction In Progress: 2457000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Construction In Progress: 2457000.00
CTRN income_statement (annual, 2025-01-31) — Cost Of Revenue: 471036000.00
CTRN income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 127326000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Accrued Expenses: 16647000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 16647000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Assets: 197060000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Assets: 197060000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Capital Lease Obligation: 47724000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 47724000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Debt And Capital Lease Obligation: 47724000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 47724000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Deferred Liabilities: 388000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 388000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Deferred Revenue: 388000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 388000.00
CTRN balance_sheet (annual, 2025-01-31) — Current Liabilities: 174391000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 174391000.00
CTRN cash_flow (annual, 2025-01-31) — Deferred Income Tax: 5247000.00
CTRN cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: 15444000.00
CTRN cash_flow (annual, 2025-01-31) — Deferred Tax: 5247000.00
CTRN cash_flow (quarterly, 2025-01-31) — Deferred Tax: 15444000.00
CTRN cash_flow (annual, 2025-01-31) — Depreciation: 18822000.00
CTRN cash_flow (quarterly, 2025-01-31) — Depreciation: 4491000.00
CTRN cash_flow (annual, 2025-01-31) — Depreciation Amortization Depletion: 18822000.00
CTRN cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 4491000.00
CTRN income_statement (annual, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 18822000.00
CTRN income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 4491000.00
CTRN cash_flow (annual, 2025-01-31) — Depreciation And Amortization: 18822000.00
CTRN cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 4491000.00
CTRN income_statement (annual, 2025-01-31) — Depreciation And Amortization In Income Statement: 18822000.00
CTRN income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 4491000.00
CTRN income_statement (annual, 2025-01-31) — Depreciation Income Statement: 18822000.00
CTRN income_statement (quarterly, 2025-01-31) — Depreciation Income Statement: 4491000.00
CTRN income_statement (annual, 2025-01-31) — Diluted Average Shares: 8315000.00
CTRN income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 8314000.00
CTRN income_statement (annual, 2025-01-31) — Diluted EPS: -5.19
CTRN income_statement (annual, 2025-01-31) — Diluted NI Availto Com Stockholders: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -14179000.00
CTRN income_statement (annual, 2025-01-31) — EBIT: -37015000.00
CTRN income_statement (quarterly, 2025-01-31) — EBIT: 1733000.00
CTRN income_statement (annual, 2025-01-31) — EBITDA: -18193000.00
CTRN income_statement (quarterly, 2025-01-31) — EBITDA: 6224000.00
CTRN cash_flow (annual, 2025-01-31) — End Cash Position: 61085000.00
CTRN cash_flow (quarterly, 2025-01-31) — End Cash Position: 61085000.00
CTRN cash_flow (annual, 2025-01-31) — Financing Cash Flow: -4664000.00
CTRN cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: -3784000.00
CTRN cash_flow (annual, 2025-01-31) — Free Cash Flow: -13957000.00
CTRN cash_flow (quarterly, 2025-01-31) — Free Cash Flow: 25997000.00
CTRN cash_flow (annual, 2025-01-31) — Gain Loss On Sale Of PPE: 27000.00
CTRN cash_flow (quarterly, 2025-01-31) — Gain Loss On Sale Of PPE: 3000.00
CTRN income_statement (annual, 2025-01-31) — Gain On Sale Of Ppe: 0.00
CTRN balance_sheet (annual, 2025-01-31) — Gross PPE: 562259000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Gross PPE: 562259000.00
CTRN income_statement (annual, 2025-01-31) — Gross Profit: 282043000.00
CTRN income_statement (quarterly, 2025-01-31) — Gross Profit: 83846000.00
CTRN income_statement (annual, 2025-01-31) — Impairment Of Capital Assets: 2536000.00
CTRN cash_flow (annual, 2025-01-31) — Income Tax Paid Supplemental Data: 415000.00
CTRN income_statement (annual, 2025-01-31) — Interest Expense: 319000.00
CTRN income_statement (quarterly, 2025-01-31) — Interest Expense: 81000.00
CTRN income_statement (annual, 2025-01-31) — Interest Expense Non Operating: 319000.00
CTRN income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 81000.00
CTRN income_statement (annual, 2025-01-31) — Interest Income: 2473000.00
CTRN income_statement (quarterly, 2025-01-31) — Interest Income: 531000.00
CTRN income_statement (annual, 2025-01-31) — Interest Income Non Operating: 2473000.00
CTRN income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 531000.00
CTRN cash_flow (annual, 2025-01-31) — Interest Paid Supplemental Data: 168000.00
CTRN cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 43000.00
CTRN balance_sheet (annual, 2025-01-31) — Inventory: 122640000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Inventory: 122640000.00
CTRN balance_sheet (annual, 2025-01-31) — Invested Capital: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Invested Capital: 113176000.00
CTRN cash_flow (annual, 2025-01-31) — Investing Cash Flow: -10108000.00
CTRN cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -2502000.00
CTRN balance_sheet (annual, 2025-01-31) — Leases: 136491000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Leases: 136491000.00
CTRN balance_sheet (annual, 2025-01-31) — Long Term Capital Lease Obligation: 172675000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 172675000.00
CTRN balance_sheet (annual, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 172675000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 172675000.00
CTRN balance_sheet (annual, 2025-01-31) — Machinery Furniture Equipment: 204314000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 204314000.00
CTRN cash_flow (annual, 2025-01-31) — Net Common Stock Issuance: -3777000.00
CTRN income_statement (annual, 2025-01-31) — Net Income: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Income Common Stockholders: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Income Continuous Operations: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -14179000.00
CTRN cash_flow (annual, 2025-01-31) — Net Income From Continuing Operations: -43170000.00
CTRN cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Income Including Noncontrolling Interests: -43170000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -14179000.00
CTRN income_statement (annual, 2025-01-31) — Net Interest Income: 2154000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Interest Income: 450000.00
CTRN income_statement (annual, 2025-01-31) — Net Non Operating Interest Income Expense: 2154000.00
CTRN income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 450000.00
CTRN cash_flow (annual, 2025-01-31) — Net Other Financing Charges: -887000.00
CTRN cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: -7000.00
CTRN balance_sheet (annual, 2025-01-31) — Net PPE: 264863000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Net PPE: 264863000.00
CTRN cash_flow (annual, 2025-01-31) — Net PPE Purchase And Sale: -10108000.00
CTRN cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -2502000.00
CTRN balance_sheet (annual, 2025-01-31) — Net Tangible Assets: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 113176000.00
CTRN balance_sheet (annual, 2025-01-31) — Non Current Deferred Assets: 0.00
CTRN balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 0.00
CTRN balance_sheet (annual, 2025-01-31) — Non Current Deferred Liabilities: 142000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 142000.00
CTRN balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Assets: 0.00
CTRN balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 0.00
CTRN balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Liabilities: 142000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Liabilities: 142000.00
CTRN income_statement (annual, 2025-01-31) — Normalized EBITDA: -15657000.00
CTRN income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 6925000.00
CTRN income_statement (annual, 2025-01-31) — Normalized Income: -41166560.00
CTRN income_statement (quarterly, 2025-01-31) — Normalized Income: -13625210.00
CTRN cash_flow (annual, 2025-01-31) — Operating Cash Flow: -3849000.00
CTRN cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 28499000.00
CTRN cash_flow (annual, 2025-01-31) — Operating Gains Losses: 27000.00
CTRN cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 3000.00
CTRN income_statement (annual, 2025-01-31) — Operating Income: -36952000.00
CTRN income_statement (quarterly, 2025-01-31) — Operating Income: 1903000.00
CTRN income_statement (annual, 2025-01-31) — Operating Revenue: 753079000.00
CTRN income_statement (quarterly, 2025-01-31) — Operating Revenue: 211172000.00
CTRN balance_sheet (annual, 2025-01-31) — Ordinary Shares Number: 8547841.00
CTRN balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 8547841.00
CTRN balance_sheet (annual, 2025-01-31) — Other Current Assets: 10216000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 10216000.00
CTRN income_statement (annual, 2025-01-31) — Other Income Expense: -2536000.00
CTRN income_statement (quarterly, 2025-01-31) — Other Income Expense: -701000.00
CTRN cash_flow (annual, 2025-01-31) — Other Non Cash Items: 48863000.00
CTRN cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 12155000.00
CTRN balance_sheet (annual, 2025-01-31) — Other Non Current Assets: 846000.00
CTRN balance_sheet (annual, 2025-01-31) — Other Non Current Liabilities: 2385000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 2385000.00
CTRN balance_sheet (annual, 2025-01-31) — Other Properties: 214148000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Other Properties: 214148000.00
CTRN balance_sheet (annual, 2025-01-31) — Payables: 102456000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Payables: 102456000.00
CTRN balance_sheet (annual, 2025-01-31) — Payables And Accrued Expenses: 119103000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 119103000.00
CTRN balance_sheet (annual, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 7176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 7176000.00
CTRN income_statement (annual, 2025-01-31) — Pretax Income: -37334000.00
CTRN income_statement (quarterly, 2025-01-31) — Pretax Income: 1652000.00
CTRN balance_sheet (annual, 2025-01-31) — Properties: 0.00
CTRN balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
CTRN cash_flow (annual, 2025-01-31) — Purchase Of PPE: -10108000.00
CTRN cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -2502000.00
CTRN balance_sheet (annual, 2025-01-31) — Receivables: 3119000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Receivables: 3119000.00
CTRN income_statement (annual, 2025-01-31) — Reconciled Cost Of Revenue: 471036000.00
CTRN income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 127326000.00
CTRN income_statement (annual, 2025-01-31) — Reconciled Depreciation: 18822000.00
CTRN income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 4491000.00
CTRN cash_flow (annual, 2025-01-31) — Repurchase Of Capital Stock: -3777000.00
CTRN balance_sheet (annual, 2025-01-31) — Retained Earnings: 275901000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 275901000.00
CTRN cash_flow (annual, 2025-01-31) — Sale Of PPE: 0.00
CTRN income_statement (annual, 2025-01-31) — Selling General And Administration: 300173000.00
CTRN income_statement (quarterly, 2025-01-31) — Selling General And Administration: 77452000.00
CTRN balance_sheet (annual, 2025-01-31) — Share Issued: 16497092.00
CTRN balance_sheet (quarterly, 2025-01-31) — Share Issued: 16497092.00
CTRN income_statement (annual, 2025-01-31) — Special Income Charges: -2536000.00
CTRN income_statement (quarterly, 2025-01-31) — Special Income Charges: -701000.00
CTRN cash_flow (annual, 2025-01-31) — Stock Based Compensation: 3302000.00
CTRN cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 868000.00
CTRN balance_sheet (annual, 2025-01-31) — Stockholders Equity: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 113176000.00
CTRN balance_sheet (annual, 2025-01-31) — Tangible Book Value: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 113176000.00
CTRN income_statement (annual, 2025-01-31) — Tax Effect Of Unusual Items: -532560.00
CTRN income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -147210.00
CTRN income_statement (annual, 2025-01-31) — Tax Provision: 5836000.00
CTRN income_statement (quarterly, 2025-01-31) — Tax Provision: 15831000.00
CTRN income_statement (annual, 2025-01-31) — Tax Rate For Calcs: 0.21
CTRN income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.21
CTRN balance_sheet (annual, 2025-01-31) — Taxes Receivable: 3119000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Taxes Receivable: 3119000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Assets: 462769000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Assets: 462769000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Capitalization: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 113176000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Debt: 220399000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Debt: 220399000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Equity Gross Minority Interest: 113176000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 113176000.00
CTRN income_statement (annual, 2025-01-31) — Total Expenses: 790031000.00
CTRN income_statement (quarterly, 2025-01-31) — Total Expenses: 209269000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Liabilities Net Minority Interest: 349593000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 349593000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Non Current Assets: 265709000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 265709000.00
CTRN balance_sheet (annual, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 175202000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 175202000.00
CTRN income_statement (annual, 2025-01-31) — Total Operating Income As Reported: -39488000.00
CTRN income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 1202000.00
CTRN income_statement (annual, 2025-01-31) — Total Unusual Items: -2536000.00
CTRN income_statement (quarterly, 2025-01-31) — Total Unusual Items: -701000.00
CTRN income_statement (annual, 2025-01-31) — Total Unusual Items Excluding Goodwill: -2536000.00
CTRN income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -701000.00
CTRN balance_sheet (annual, 2025-01-31) — Treasury Shares Number: 7949251.00
CTRN balance_sheet (quarterly, 2025-01-31) — Treasury Shares Number: 7949251.00
CTRN balance_sheet (annual, 2025-01-31) — Treasury Stock: 270988000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Treasury Stock: 270988000.00
CTRN balance_sheet (annual, 2025-01-31) — Working Capital: 22669000.00
CTRN balance_sheet (quarterly, 2025-01-31) — Working Capital: 22669000.00
CTRN income_statement (quarterly, 2025-04-30) — +Operating Expense: 79257000.00
CTRN income_statement (quarterly, 2025-04-30) — +Total Revenue: 201728000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 80919000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -293473000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 108928000.00
CTRN cash_flow (quarterly, 2025-04-30) — Asset Impairment Charge: 64000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Assets Held For Sale Current: 247000.00
CTRN income_statement (quarterly, 2025-04-30) — Basic Average Shares: 8034000.00
CTRN income_statement (quarterly, 2025-04-30) — Basic EPS: 0.11
CTRN cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 61085000.00
CTRN cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -2104000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 220389000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Capital Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 41556000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 41556000.00
CTRN cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -6456000.00
CTRN cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -2104000.00
CTRN cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -10969000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -21911000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Accrued Expense: -16825000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Inventory: 12709000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -453000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 2000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Payable: -21911000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -38736000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -3016000.00
CTRN cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -29494000.00
CTRN cash_flow (quarterly, 2025-04-30) — Changes In Cash: -19529000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Common Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 108559000.00
CTRN cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -6315000.00
CTRN income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 121918000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 14315000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Assets: 168603000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 44592000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 44592000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 908000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 908000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 150472000.00
CTRN cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 0.00
CTRN cash_flow (quarterly, 2025-04-30) — Deferred Tax: 0.00
CTRN cash_flow (quarterly, 2025-04-30) — Depreciation: 4370000.00
CTRN cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 4370000.00
CTRN income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 4370000.00
CTRN cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 4370000.00
CTRN income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 4370000.00
CTRN income_statement (quarterly, 2025-04-30) — Depreciation Income Statement: 4370000.00
CTRN income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 8170000.00
CTRN income_statement (quarterly, 2025-04-30) — Diluted EPS: 0.11
CTRN income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — EBIT: 947000.00
CTRN income_statement (quarterly, 2025-04-30) — EBITDA: 5317000.00
CTRN cash_flow (quarterly, 2025-04-30) — End Cash Position: 41556000.00
CTRN cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -6456000.00
CTRN cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -13073000.00
CTRN cash_flow (quarterly, 2025-04-30) — Gain Loss On Sale Of PPE: 0.00
CTRN balance_sheet (quarterly, 2025-04-30) — Gross PPE: 560979000.00
CTRN income_statement (quarterly, 2025-04-30) — Gross Profit: 79810000.00
CTRN income_statement (quarterly, 2025-04-30) — Interest Expense: 76000.00
CTRN income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 76000.00
CTRN income_statement (quarterly, 2025-04-30) — Interest Income: 458000.00
CTRN income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 458000.00
CTRN cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 43000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Inventory: 109931000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Invested Capital: 108559000.00
CTRN cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -2104000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 175797000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 175797000.00
CTRN cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -6315000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 871000.00
CTRN cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 871000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Interest Income: 382000.00
CTRN income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 382000.00
CTRN cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -141000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Net PPE: 267506000.00
CTRN cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -2104000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 108559000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 142000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 142000.00
CTRN income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 5381000.00
CTRN income_statement (quarterly, 2025-04-30) — Normalized Income: 935000.00
CTRN cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -10969000.00
CTRN income_statement (quarterly, 2025-04-30) — Operating Income: 553000.00
CTRN income_statement (quarterly, 2025-04-30) — Operating Revenue: 201728000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 8547841.00
CTRN balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 13752000.00
CTRN income_statement (quarterly, 2025-04-30) — Other Income Expense: -64000.00
CTRN cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 12252000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 1299000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 2438000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Other Properties: 560979000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Payables: 80919000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 95234000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 9738000.00
CTRN income_statement (quarterly, 2025-04-30) — Pretax Income: 871000.00
CTRN cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -2104000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Receivables: 3117000.00
CTRN income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 121918000.00
CTRN income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 4370000.00
CTRN cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -6315000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 276772000.00
CTRN income_statement (quarterly, 2025-04-30) — Selling General And Administration: 74887000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Share Issued: 8547841.00
CTRN income_statement (quarterly, 2025-04-30) — Special Income Charges: -64000.00
CTRN cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 968000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 108559000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 108559000.00
CTRN income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
CTRN income_statement (quarterly, 2025-04-30) — Tax Provision: 0.00
CTRN income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
CTRN balance_sheet (quarterly, 2025-04-30) — Taxes Receivable: 3117000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Assets: 437408000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 108559000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Debt: 220389000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 108559000.00
CTRN income_statement (quarterly, 2025-04-30) — Total Expenses: 201175000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 328849000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 268805000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 178377000.00
CTRN income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 489000.00
CTRN income_statement (quarterly, 2025-04-30) — Total Unusual Items: -64000.00
CTRN income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -64000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 277303000.00
CTRN balance_sheet (quarterly, 2025-04-30) — Working Capital: 18131000.00
CTRN income_statement (quarterly, 2025-04-30) — Write Off: 64000.00
CTRN income_statement (quarterly, 2025-07-31) — +Operating Expense: 83453000.00
CTRN income_statement (quarterly, 2025-07-31) — +Total Revenue: 190750000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 96245000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -293603000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 109791000.00
CTRN cash_flow (quarterly, 2025-07-31) — Asset Impairment Charge: 263000.00
CTRN income_statement (quarterly, 2025-07-31) — Basic Average Shares: 8033000.00
CTRN income_statement (quarterly, 2025-07-31) — Basic EPS: 0.48
CTRN cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 41556000.00
CTRN cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -5601000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 217489000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Capital Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 50397000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 50397000.00
CTRN cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -619000.00
CTRN cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: 5605000.00
CTRN cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 3855000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 14786000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Accrued Expense: -10781000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Inventory: -7635000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: 37000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: 1511000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Payable: 14786000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 4005000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -5461000.00
CTRN cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -7543000.00
CTRN cash_flow (quarterly, 2025-07-31) — Changes In Cash: 8841000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Common Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 113240000.00
CTRN cash_flow (quarterly, 2025-07-31) — Common Stock Payments: 0.00
CTRN income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 114477000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 17285000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Assets: 189204000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 43344000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 43344000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 1330000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 1330000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 167376000.00
CTRN cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: 0.00
CTRN cash_flow (quarterly, 2025-07-31) — Deferred Tax: 0.00
CTRN cash_flow (quarterly, 2025-07-31) — Depreciation: 4548000.00
CTRN cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 4548000.00
CTRN income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 4548000.00
CTRN cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 4548000.00
CTRN income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 4548000.00
CTRN income_statement (quarterly, 2025-07-31) — Depreciation Income Statement: 4548000.00
CTRN income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 8314000.00
CTRN income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.46
CTRN income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — EBIT: 3906000.00
CTRN income_statement (quarterly, 2025-07-31) — EBITDA: 8454000.00
CTRN cash_flow (quarterly, 2025-07-31) — End Cash Position: 50397000.00
CTRN cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -619000.00
CTRN cash_flow (quarterly, 2025-07-31) — Free Cash Flow: -1746000.00
CTRN cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of PPE: -10802000.00
CTRN income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: 10960000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Gross PPE: 560545000.00
CTRN income_statement (quarterly, 2025-07-31) — Gross Profit: 76273000.00
CTRN income_statement (quarterly, 2025-07-31) — Impairment Of Capital Assets: 263000.00
CTRN income_statement (quarterly, 2025-07-31) — Interest Expense: 88000.00
CTRN income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 88000.00
CTRN income_statement (quarterly, 2025-07-31) — Interest Income: 389000.00
CTRN income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 389000.00
CTRN cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 55000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Inventory: 117566000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Invested Capital: 113240000.00
CTRN cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: 5605000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 174145000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 174145000.00
CTRN cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: 0.00